Legal provisions
DIN1: What is title and date of enactment of the drug law/regulations and the article number of the provision requiring inspection of distribution channels?
________________________________________________________________
DIN2: Are there provisions in the drug law/regulations that define the powers and status of the inspectors?
Yes
No
DIN2.1: If yes, what are the powers of distribution channel inspectors?
________________________________________________________________
Organization
DIN3: Is there a distribution channel inspectorate?
Yes
No
DIN3.1: If yes, to whom does it report?
________________________________________________________________
DIN4: What is the relationship of the inspectorate with other bodies involved in drug regulation, particularly with the licensing unit?
________________________________________________________________
DIN5: Are there written guidelines for Good Distribution Practices (GDP)?
Yes
No
DIN5.1: If yes, give reference to title and date of publication of the guidelines:
________________________________________________________________
DIN6: Is there a job description pertaining to the duties and responsibilities of distribution channel inspectors?
Yes
No
DIN7: Are there inspection guidelines or SOP for inspectors of distribution channels?
Yes
No
DIN7.1: If yes, give reference to the date of publication of the guidelines or SOP:
________________________________________________________________
Human resources
DIN8: How many distribution channel inspectors are there in the whole country?
(a) Full-time ____________
(b) Part-time ____________
DIN9: Do inspectors of distribution channels receive training in distribution channel inspection?
Yes
No
DIN9.1: If yes, collect information on the qualifications, training and experience of the inspectors.
Qualification |
Training offered |
Experience |
| |
|
|
| |
|
|
DIN10: What is the average net monthly salary of a distribution channel inspector compared to other categories indicated in the table?
Categories of staff |
Salary (US$) |
Inspector of distribution channels |
|
Pharmacist working in a private retail pharmacy |
|
Pharmacist working in a private hospital pharmacy |
|
Pharmacist working in an import/wholesale distribution channel |
|
Financing of distribution channel inspection
DIN11: Is there a specific budget for the distribution channel inspectorate?
Yes
No
DIN11.1: If yes, what was the budget of the distribution channel inspectorate during each of the last five years (US$):
Budget section |
Year: |
Year: |
Year: |
Year: |
Year: |
Capital budget |
|
|
|
|
|
Salaries |
|
|
|
|
|
Miscellaneous |
|
|
|
|
|
Total |
|
|
|
|
|
DIN11.2: What was the source of the budget in the last five years (answer yes/no)?
Source |
Year: |
Year: |
Year: |
Year: |
Year: |
Government |
|
|
|
|
|
Fees |
|
|
|
|
|
Other (specify): |
|
|
|
|
|
DIN11.3: If the answer to DIN11 is no, what was the estimated expenditure of the distribution channel inspectorate in the last five years?
Estimated expenditure |
Year: |
Year: |
Year: |
Year: |
Year: |
US$ |
|
|
|
|
|
Local currency |
|
|
|
|
|
DIN12: If fees are collected for inspection services, collect information on the types of inspection services on which fees have been levied and the amount of the fees charged.
Type of inspection services on which fees are levied |
Fees charged (US$) |
| |
|
| |
|
| |
|
Activities
DIN13: Is responsibility for inspecting distribution channels decentralized?
Yes
No
DIN13.1: If yes, which body conducts inspections at the following levels?
Level of inspection |
Inspecting body |
Capital city (central) |
|
Provincial/state/regional level |
|
District level |
|
Peripheral level |
|
Customs warehouse or ports of entry |
|
DIN14: What is the structural and functional relationship between the various inspection levels? Is there a reporting mechanism? Explain.
________________________________________________________________
DIN15: Are there planned inspections of distribution channels at the different levels?
Yes
No
DIN15.1: If yes, what is the number of planned inspections conducted, out of the total number of planned inspections targeted in each of the last five years? (If possible, give information about each level.)
Planned inspections |
Year: |
Year: |
Year: |
Year: |
Year: |
Planned inspections targeted |
|
|
|
|
|
Planned inspections carried out |
|
|
|
|
|
DIN16: What are the different enforcement measures (administrative or legal sanctions) taken against those who do not comply with the drug laws/regulations? Explain.
Administrative measures |
Legal sanctions |
| |
|
| |
|
| |
|
| |
|
DIN17: Give information below on the total number of violations registered and the number of the different enforcement measures taken in each of the last five years. (If other enforcement strategies are used, describe them.)
Violations and enforcement measures taken |
Year: |
Year: |
Year: |
Year: |
Year: |
Total number of violations |
|
|
|
|
|
Warning letters issued |
|
|
|
|
|
Fines |
|
|
|
|
|
Imprisonment |
|
|
|
|
|
Suspension of licence |
|
|
|
|
|
Revocation of licence |
|
|
|
|
|
Others (specify): |
|
|
|
|
|
DIN18: Do the inspectors collect samples from distribution channels as part of planned quality surveillance activities?
Yes
No
DIN18.1: If yes, provide the following information for each of the last two years:
Samples collected in connection with: |
Number of samples collected |
Passed lab. test |
Failed lab. test |
| |
Year: |
Year: |
Year: |
Year: |
Year: |
Year: |
Planned quality surveillance |
|
|
|
|
|
|
Follow-up of complaints |
|
|
|
|
|
|
Target testing/risk assessment |
|
|
|
|
|
|
Others (specify): |
|
|
|
|
|
|
Total |
|
|
|
|
|
|
DIN18.2: If the testing is targeted against a limited list of products, what are the products and what criteria are used for selecting them? If there is a written sampling procedure for inspectors provide information:
________________________________________________________________
DIN19: What actions/sanctions have been taken against products that failed laboratory test in each of the last two years?
DIN20 If inspectors of distribution channels have found any of the following in their planned inspection activities in the last two years, provide information below:
Inspection finding |
Number of cases found |
| |
Year: |
Year: |
Unlicensed pharmaceutical premises, (manufacturing, import, wholesale and retail) |
|
|
Premises operated by nonprofessionals (not in accordance with the law) |
|
|
Unrenewed/expired licences |
|
|
Counterfeit products |
|
|
Illegally imported products |
|
|
Sale of expired products |
|
|
Unregistered products |
|
|
Products stored under improper conditions |
|
|
Products not authorized to be sold in the establishment |
|
|
Other (specify): |
|
|
DIN21: Are quality requirements for drug products for export purposes the same as for those products for use within the country? Explain:
________________________________________________________________
Monitoring and evaluation
DIN22: Is there an audit and/or review system to examine the performance of inspectors and the inspectorate?
Yes
No
DIN22.1: If yes, indicate whether this is external, internal or both:
________________________________________________________________
DIN23: What actions have been taken as a result of the audits or reviews in the last five years?
| |
Year: |
Year: |
Year: |
Year: |
Year: |
Actions taken |
|
|
|
|
|
DIN24: What are the main constraints, weaknesses or problems and the strengths of distribution channel inspection in the country?
Constraints/weaknesses/problems |
Strengths |
| |
|
| |
|
| |
|
|
Indicators
1. Number of pharmaceutical distribution channels (importers, wholesalers, dispensing outlets) inspected, out of the total number of licensed pharmaceutical distribution channels (importers, wholesalers, dispensing outlets) in the country (indicate year).
2. Number of planned distribution channel inspections carried out, out of the total number of planned distribution channel inspections (indicate year).
3. Number of pharmaceutical distribution channels in violation of the regulations, out of the total number of licensed pharmaceutical distribution channels inspected (indicate year).
4. Number of samples collected, out of the total number of samples planned to be collected (indicate year).
5. Number of drug products beyond the expiry date, out of the total number of drug products collected from pharmaceutical distribution channels (indicate year).
|
If other strategies are used to prevent mistakes or improve compliance with the requirements of good distribution practice, describe them.
If there is any specific and important information that is not covered by the above questions, please provide additional information as appropriate.